Correlation Between NRx Pharmaceuticals and Relief Therapeutics
Can any of the company-specific risk be diversified away by investing in both NRx Pharmaceuticals and Relief Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRx Pharmaceuticals and Relief Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NRx Pharmaceuticals and Relief Therapeutics Holding, you can compare the effects of market volatilities on NRx Pharmaceuticals and Relief Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRx Pharmaceuticals with a short position of Relief Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRx Pharmaceuticals and Relief Therapeutics.
Diversification Opportunities for NRx Pharmaceuticals and Relief Therapeutics
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between NRx and Relief is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding NRx Pharmaceuticals and Relief Therapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relief Therapeutics and NRx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRx Pharmaceuticals are associated (or correlated) with Relief Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relief Therapeutics has no effect on the direction of NRx Pharmaceuticals i.e., NRx Pharmaceuticals and Relief Therapeutics go up and down completely randomly.
Pair Corralation between NRx Pharmaceuticals and Relief Therapeutics
Assuming the 90 days horizon NRx Pharmaceuticals is expected to generate 1.59 times more return on investment than Relief Therapeutics. However, NRx Pharmaceuticals is 1.59 times more volatile than Relief Therapeutics Holding. It trades about 0.19 of its potential returns per unit of risk. Relief Therapeutics Holding is currently generating about -0.13 per unit of risk. If you would invest 5.10 in NRx Pharmaceuticals on September 24, 2024 and sell it today you would earn a total of 1.60 from holding NRx Pharmaceuticals or generate 31.37% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 95.0% |
Values | Daily Returns |
NRx Pharmaceuticals vs. Relief Therapeutics Holding
Performance |
Timeline |
NRx Pharmaceuticals |
Relief Therapeutics |
NRx Pharmaceuticals and Relief Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with NRx Pharmaceuticals and Relief Therapeutics
The main advantage of trading using opposite NRx Pharmaceuticals and Relief Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRx Pharmaceuticals position performs unexpectedly, Relief Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relief Therapeutics will offset losses from the drop in Relief Therapeutics' long position.NRx Pharmaceuticals vs. Fate Therapeutics | NRx Pharmaceuticals vs. Sana Biotechnology | NRx Pharmaceuticals vs. Caribou Biosciences | NRx Pharmaceuticals vs. Arcus Biosciences |
Relief Therapeutics vs. NRx Pharmaceuticals | Relief Therapeutics vs. NRX Pharmaceuticals | Relief Therapeutics vs. Pasithea Therapeutics Corp | Relief Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |